About: Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Cíl: cílem této studie bylo zhodnotit vliv orálně podávaného vitamínu E na sérové koncentrace několika markerů mikrozánětu a kardiovaskulární choroby u chronicky hemodialyzovaných (HD) pacientů. Výsledky: u pacientů s HD byly základní sérové hladiny PAPP-A a CRP signifikantně vyšší než u zdravých kontrol. Po 5 týdnech suplementace vitamínem E se sérové koncentrace všech vyšetřovaných markerů u pacientů s HD nezměnily. Závěr: chronický mikrozánět u pacientů s HD je spojen se zvýšením hladin CRP a PAPPA-A. Denní orální dávka 400 mg vitamínu E se zdá být neúčinná u pacientů s HD. (cs)
  • The aim of this study was to evaluate the influence of oral vitamin E therapy on serum concentrations of several markers of micro-inflammation and cardiovascular disease in chronic hemodialysis (HD) patients. 29 HD patients were randomized into two groups: 15 patients were treated orally with 400mg of vitamin E daily for a period of five weeks, and 14 patients received no antioxidant supplementation. Before and after vitamin E therapy, serum concentrations of vitamin E (high-performance liquid chromatography), pregnancy-associated plasma protein-A (immunochemical - TRACE assay), C-reactive protein (nephelometry), intercellular adhesion molecule-1 (ELISA), and E-selectin (ELISA) were measured. HD patients were compared with 16 healthy controls. Conclusion. Chronic micro-inflammation in HD patients is documented by the elevation of CRP and PAPPA. A daily oral dose of 400 mg of vitamin E does not seem to be able to reduce enhanced oxidative stress and micro-inflammation in chronic HD patients.
  • The aim of this study was to evaluate the influence of oral vitamin E therapy on serum concentrations of several markers of micro-inflammation and cardiovascular disease in chronic hemodialysis (HD) patients. 29 HD patients were randomized into two groups: 15 patients were treated orally with 400mg of vitamin E daily for a period of five weeks, and 14 patients received no antioxidant supplementation. Before and after vitamin E therapy, serum concentrations of vitamin E (high-performance liquid chromatography), pregnancy-associated plasma protein-A (immunochemical - TRACE assay), C-reactive protein (nephelometry), intercellular adhesion molecule-1 (ELISA), and E-selectin (ELISA) were measured. HD patients were compared with 16 healthy controls. Conclusion. Chronic micro-inflammation in HD patients is documented by the elevation of CRP and PAPPA. A daily oral dose of 400 mg of vitamin E does not seem to be able to reduce enhanced oxidative stress and micro-inflammation in chronic HD patients. (en)
Title
  • Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients
  • Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients (en)
  • Vliv perorální podávání vitaminu E na mikrozánět a markery kardiovakulárního poškození u chronicky hemodialyzovaných pacientů (cs)
skos:prefLabel
  • Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients
  • Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients (en)
  • Vliv perorální podávání vitaminu E na mikrozánět a markery kardiovakulárního poškození u chronicky hemodialyzovaných pacientů (cs)
skos:notation
  • RIV/00216208:11150/06:00004991!RIV08-MSM-11150___
http://linked.open.../vavai/riv/strany
  • 395;399
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • P(NR8094), S, Z(MSM0021620812)
http://linked.open...iv/cisloPeriodika
  • 5
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 479462
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11150/06:00004991
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Influence; Vitamin; Therapy; Micro-Inflammation; Cardiovascular; Disease; Markers; Chronic; Hemodialysis; Patients (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [8D187D272651]
http://linked.open...i/riv/nazevZdroje
  • Renal Failure
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 28
http://linked.open...iv/tvurceVysledku
  • Dusilová-Sulková, Sylvie
http://linked.open...n/vavai/riv/zamer
issn
  • 0886-022X
number of pages
http://localhost/t...ganizacniJednotka
  • 11150
is http://linked.open...avai/riv/vysledek of
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software